Stuart Bryan 4
4 · Fulcrum Therapeutics, Inc. · Filed Jul 18, 2019
Insider Transaction Report
Form 4
Stuart Bryan
Chief Operating Officer
Transactions
- Award
Stock Option (right to buy)
2019-07-18+28,571→ 28,571 totalExercise: $16.00Exp: 2029-07-17→ Common Stock (28,571 underlying)
Footnotes (1)
- [F1]The option was granted on July 18, 2019. The shares underlying the option are scheduled to vest in equal quarterly installments from July 1, 2019 through June 30, 2023.